Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome

Gu-Lao Zhang(First Affiliated Hospital of Jiangxi Medical College), Hengli Lai(First Affiliated Hospital of Jiangxi Medical College)
World Journal of Diabetes
April 11, 2024
Cited by 10


Related Papers